Key Financial Data Of Reporting Company

Genky DrugStores Co., Ltd. - Filing #7287011

Concept As at
2024-12-20
2024-06-21 to
2024-12-20
As at
2024-06-20
2023-06-21 to
2024-06-20
2023-06-21 to
2023-12-20
As at
2023-12-20
Key financial data of reporting company
Business results of reporting company
Net sales
98,758,000,000 JPY
184,860,000,000 JPY
91,967,000,000 JPY
Ordinary profit (loss)
4,722,000,000 JPY
9,268,000,000 JPY
4,495,000,000 JPY
Net assets
49,793,000,000 JPY
46,681,000,000 JPY
43,592,000,000 JPY
Total assets
119,916,000,000 JPY
113,939,000,000 JPY
108,300,000,000 JPY
Basic earnings (loss) per share
107.55
208.21
101.66
Diluted earnings per share
107.33
207.94
101.55
Equity-to-asset ratio
0.414 xbrli:pure
0.409 xbrli:pure
0.402 xbrli:pure
Net cash provided by (used in) operating activities
5,676,000,000 JPY
13,256,000,000 JPY
5,702,000,000 JPY
Net cash provided by (used in) investing activities
-6,849,000,000 JPY
-10,631,000,000 JPY
-5,852,000,000 JPY
Net cash provided by (used in) financing activities
2,221,000,000 JPY
-2,058,000,000 JPY
-1,115,000,000 JPY
Cash and cash equivalents
6,943,000,000 JPY
5,896,000,000 JPY
4,064,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.